Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age Factor”

176 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 176 results

Not applicableStudy completedNCT01571076
What this trial is testing

Preimplantation Genetic Screening (PGS) in Advanced Female Age and Male Severe Factor

Who this might be right for
Embryo AneuploidiesImplantation RatesInfertility
Igenomix 240
Not applicableStudy completedNCT05542381
What this trial is testing

The Role of Loteprednol in Reducing Post-Intravitreal Injection Related Pain

Who this might be right for
Age-Related Macular Degeneration
Virginia Polytechnic Institute and State University 64
Large-scale testing (Phase 3)Study completedNCT00637377
What this trial is testing

Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration (AMD)

Who this might be right for
Macular Degeneration
Bayer 1,240
Large-scale testing (Phase 3)Study completedNCT00509795
What this trial is testing

Vascular Endothelial Growth Factor VEGF Trap-Eye:Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration(AMD)

Who this might be right for
Macular Degeneration
Regeneron Pharmaceuticals 1,217
Large-scale testing (Phase 3)Study completedNCT04964089
What this trial is testing

Evaluate the Efficacy and Safety of Intravitreal KSI-301 Compared With Intravitreal Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD)

Who this might be right for
Wet Age-related Macular Degeneration
Kodiak Sciences Inc 557
Large-scale testing (Phase 3)Active Not RecruitingNCT06556368
What this trial is testing

Evaluate the Efficacy and Safety of Tarcocimab Tedromer and Tabirafusp Tedromer Compared to Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD) - DAYBREAK

Who this might be right for
Wet Age-related Macular Degeneration
Kodiak Sciences Inc 675
Not applicableEnded earlyNCT01314846
What this trial is testing

Co-culture and Advanced Maternal Age in PGS Program

Who this might be right for
Age Factors
IVI Madrid 346
Post-approval studies (Phase 4)Not Yet RecruitingNCT07187804
What this trial is testing

Long Term Efficacy of Faricimab Using a Treat and Extend Regimen for Type 3 Macular Neovascularization

Who this might be right for
Age-related Macular Degeneration (ARMD)Choroidal NeovascularizationAnti-vascular Endothelial Growth Factor
Kim's Eye Hospital 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT05769153
What this trial is testing

Study of AR-14034 in Participants With Neovascular Age-Related Macular Degeneration (nAMD)

Who this might be right for
Neovascular Age-related Macular Degeneration (nAMD)
Alcon Research 139
Not applicableStudy completedNCT01350323
What this trial is testing

Aqueous Vascular Endothelial Growth Factor (VEGF) Levels in Type 3 Neovascularization

Who this might be right for
Age-related Macular Degeneration
University of Molise 33
Not applicableStudy completedNCT01329523
What this trial is testing

Compare Genetic Variations of IGF-I and IGF-II

Who this might be right for
Dementia
Avera McKennan Hospital & University Health Center 50
Not applicableStudy completedNCT06953427
What this trial is testing

The Impact of Age on Short-term Post-thrombectomy Outcomes in Patients Aged 70 or Beyond With Acute Ischemic Stroke

Who this might be right for
Acute Cerebral IschemiaEndovascular ThrombectomyPrognosis+3 more
Kuang Tien General Hospital 94
Not applicableStudy completedNCT02452840
What this trial is testing

Photodynamic Therapy for PDA in NV AMD

Who this might be right for
Neovascular Age-related Macular DegenerationMacular Degeneration
Duke University 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT06116890
What this trial is testing

Study to Assess the Efficacy & Safety of KHK4951 in Patients With Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration (nAMD)
Kyowa Kirin Co., Ltd. 180
Not applicableEnded earlyNCT02823262
What this trial is testing

A Breast Cancer Treatment Decision Aid for Women Aged 70 and Older

Who this might be right for
Breast CancerEstrogen Receptor Positive Breast CancerNode-negative Breast Cancer+1 more
Beth Israel Deaconess Medical Center 65
Testing effectiveness (Phase 2)Active Not RecruitingNCT05984927
What this trial is testing

NG101 AAV Gene Therapy in Subjects With Wet Age-Related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
Elisigen, Inc. 20
Not applicableStudy completedNCT02808546
What this trial is testing

The Risk Factors of Symptomatic Gallbladder Stone: Age-Sex Matched Case-control Study Performed in Single Institute

Who this might be right for
Gallstone
Cheju Halla General Hospital 342
Large-scale testing (Phase 3)Study completedNCT05666804
What this trial is testing

Study Assessing the Efficacy and Safety of a Personalized Monotherapy Regimen of Brolucizumab in Patients With Symptomatic Macular Polypoidal Choroidal Vasculopathy

Who this might be right for
Macular Polypoidal Choroidal Vasculopathy (PCV)
Novartis Pharmaceuticals 148
Testing effectiveness (Phase 2)WithdrawnNCT03446144
What this trial is testing

Safety and Efficacy of IONIS-FB-Lrx in up to 120 Patients 55 and Older With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)

Who this might be right for
Geographic AtrophyAge Related Macular Degeneration
Ionis Pharmaceuticals, Inc.
Post-approval studies (Phase 4)Study completedNCT02257632
What this trial is testing

Systemic Vascular Endothelial Growth Factor (VEGF) Protein Dynamics Following Intravitreal Injections of Ranibizumab Versus Aflibercept in Patients With Neovascular Age-related Macular Degeneration

Who this might be right for
Wet Age-Related Macular Degeneration
Novartis Pharmaceuticals 41
Next Page